CSL Ltd is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.
CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.
The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
The main annual technical chart says, in the year 2025 CSL stock goes the worst year since 2002 (where it halved in price, and even more) after unprecedented 400x run over the past 30-year time span, while its RSI(14) rocketed above '90' for a straight seven years in a row.
We watch close its further potential bearish action, with tap & hold '70-80' area, that is near CSL 30-year average.
--
Best wishes,
PandorraResearch Team
CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.
The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
The main annual technical chart says, in the year 2025 CSL stock goes the worst year since 2002 (where it halved in price, and even more) after unprecedented 400x run over the past 30-year time span, while its RSI(14) rocketed above '90' for a straight seven years in a row.
We watch close its further potential bearish action, with tap & hold '70-80' area, that is near CSL 30-year average.
--
Best wishes,
PandorraResearch Team
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.